Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-08-10Clinical Trial Update: NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer [Phase 2]
The Phase 2 trial of NovoTTF-100A Therapy for refractory CNS-involved small cell lung cancer (including brain metastases) has been withdrawn…
-
CLINICAL_TRIALS research · 2017-08-10Clinical Trial Update: Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
A clinical trial update outlining the use of next-generation sequencing in small cell lung cancer to identify a susceptibility gene and to a…
-
CLINICAL_TRIALS research · 2017-07-26Clinical Trial Update: Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC [Phase 2]
Phase 2 clinical trial evaluating nab-paclitaxel in patients with sensitive and refractory relapsed small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating chloroquine as an anti-autophagic radiosensitizer in stage I-III small cell lung cancer; the trial status …
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated bendamustine with irinotecan followed by etoposide/carboplatin in extensive-stage small cell lung canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies [NA]
Clinical trial update on early palliative care in advanced lung and gastrointestinal malignancies; status completed with results posted in 2…
-
FDA approval · 2017-07-06FDA Approved: TOPOTECAN — Original Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s original application for a generic Topotecan. This approval makes a generic version of Topotecan a…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating carboplatin and etoposide in combination with LBH589 (panobinostat) for small cell lung cancer was terminated. Th…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating pemetrexed in combination with gemcitabine for newly diagnosed extensive-stage small cell lung cancer; the trial wa…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Abraxane in combination with carboplatin for small cell lung cancer. The study was terminated and results were post…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer [Phase 2]
Phase 2 trial of ADI-PEG 20 in relapsed sensitive or refractory small cell lung cancer was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) [Phase 2]
This is a Phase 2 clinical trial update evaluating an oral radiation sensitizer in newly diagnosed small cell lung cancer. The study status …
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors [Phase 1]
This document reports results from a Phase 1 bioequivalence study comparing two oral formulations of Topotecan in patients with advanced sol…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC) [Phase 2]
A Phase 2 study evaluating concurrent chemotherapy with intensity-modulated radiotherapy for limited-stage small cell lung cancer. The trial…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 study of Seneca Valley Virus-001 after chemotherapy in extensive-stage small cell lung cancer was terminated; results were posted in…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating irinotecan and carboplatin in metastatic or recurrent small cell lung cancer completed; results posted.
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
A Phase 1 clinical trial of talazoparib in patients with advanced or metastatic solid tumors unsuitable for surgery and with liver or kidney…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors [Phase 2]
A Phase 2a trial of desipramine in small cell lung cancer and other high-grade neuroendocrine tumors was terminated, with results posted in …
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of Hsp90 inhibitor STA-9090 (ganetespib) in relapsed or refractory small cell lung cancer has completed; results post…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer [Phase 2]
A Phase 2 trial evaluated zoledronic acid (Zometa) for bone metastases in lung cancer (including non-small cell and small cell) and was term…
-
CLINICAL_TRIALS research · 2017-04-04Clinical Trial Update: Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
A retrospective, multi-indication study sponsored by Optimata Ltd. to validate PrediCare's ability to predict Time To Progression in cancer …
-
FDA approval · 2017-03-17FDA Approved: CISPLATIN — Original Application (Sagent Pharmaceuticals)
FDA approved Sagent Pharmaceuticals' original application for cisplatin, a generic injectable chemotherapy agent (ANDA approval).
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Study of Arsenic Trioxide in Small Cell Lung Cancer [Phase 2]
Phase 2 trial of arsenic trioxide for small cell lung cancer has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing Topotecan + Cisplatin vs Etoposide + Cisplatin as first-line therapy for extensive-disease small cell lung cancer …
-
CLINICAL_TRIALS withdrawal · 2017-02-07Clinical Trial Update: MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases [Phase 2]
Phase 2 trial of MRI-guided High Intensity Focused Ultrasound (HIFU) with ThermoDox for palliation of painful bone metastases has been withd…